Clinical Trial Update: A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the effectiveness, safety, and cost-effectiveness of dapagliflozin versus empagliflozin in adults with type 2 diabetes and hi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Jardiance (empagliflozin)

Snippet

Sponsor: Bhavya Bhavya, MD | Conditions: Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING